{"nctId":"NCT00704028","briefTitle":"Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency Anemia","startDateStruct":{"date":"2008-06"},"conditions":["Anemia"],"count":161,"armGroups":[{"label":"Ferric Carboxymaltose (FCM)","type":"EXPERIMENTAL","interventionNames":["Drug: Ferric Carboxymaltose"]},{"label":"Iron Dextran","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Iron Dextran"]}],"interventions":[{"name":"Ferric Carboxymaltose","otherNames":[]},{"name":"Iron Dextran","otherNames":["Dexferrum, INFeD"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects ≥18 years of age and able to give informed consent\n* Iron deficiency is the primary etiology of anemia\n* History of intolerance or an unsatisfactory response to oral iron\n* Screening Visit central laboratory Hgb ≤11 g/dL\n* Screening Visit ferritin ≤100 ng/mL or ≤300 when TSAT was ≤30%\n\nExclusion Criteria:\n\n* Previous participation in a FCM trial\n* Known hypersensitivity reaction to FCM or iron dextran\n* Requires dialysis for treatment of chronic kidney disease\n* Current anemia not attributed to iron deficiency\n* Received IV iron, RBC transfusion(s), or antibiotics 10 days prior and during the screening phase\n* Anticipated need for surgery during the 30 day period prior to screening or during the study period\n* AST or ALT greater than 1.5 times the upper limit of normal\n* Received an investigational drug within 30 days of screening\n* Women who are breastfeeding\n* Pregnant or sexually-active females who are not willing to use an effective form of birth control","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Number of Subjects Who Reported Treatment-emergent Adverse Events (AE's)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60","spread":null},{"groupId":"OG001","value":"59","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":5,"n":82},"commonTop":["Nausea","Headache","Dizziness","Vomiting","Diarrhea"]}}}